Abstract:BACKGROUND:Stem cell transplantation offers a promising treatment for heart failure. Recent studies show that both c-kit positive cardiac stem cells (CSCs) and bone marrow-derived mesenchymal stem cells (BM-MSCs) are good candidates for stem cell therapy to treat heart failure; however, the exact mechanism of stem cell therapy in improving cardiac function of ischemic cardiomyopathy is not fully known. Our objective was to test our hypothesis that CSCs and/or BM-MSCs repair the damaged heart by boosting post-myocardial infarction (MI) angiogenesis in a paracrine manner. METHODS AND RESULTS:We isolated and purified CSCs and BM-MSCs from rats. Intramyocardial injections of CSCs and/or BM-MSCs were performed at 28 days after MI. We applied cardiac ultrasound and histological analysis to evaluate the effect of cell therapy on cardiac function and cardiac remodeling. In vivo donor cell transplantation experiments showed that CSCs and/or BM-MSCs improved cardiac function after MI and reduced infarct size. However, in vivo cell tracking experiments showed that minimal donor cells remained in the myocardium after cell transplantation. Our further in vitro and in vivo experiments showed that transplantation of CSCs enhanced the expression of pro-angiogenic factors and boosted post-MI angiogenesis in the myocardium in a paracrine manner, which in part contributed to the effect of CSCs on cardiac recovery after MI. CSCs and BM-MSCs synergistically inhibited CSC/BM-MSC apoptosis and enhanced their proliferation in a paracrine manner. This resulted in a larger number of transplanted cells remaining in the post-MI myocardium after coinjection of CSCs and BM-MSCs, and therefore the accumulation of more pro-angiogenic factors in the heart tissue compared to transplantation of CSCs or MSCs alone. Consequently, transplantation of both CSCs and BM-MSCs was superior to transplantation of either CSCs or BM-MSCs alone to boost post-MI angiogenesis and improve cardiac function after MI. CONCLUSION:C-kit+ CSC and/or BM-MSC transplantation can improve cardiac function after MI in a paracrine manner. Coinjection of both CSCs and BM-MSCs improves cardiac function more significantly than CSC or BM-MSC transplantation alone in a paracrine manner by improving the engraftment of donor cells and boosting the expression of multiple pro-angiogenic factors.

Epigenetic Regulation of Cardiac Progenitor Cells Marker C-Kit by Stromal Cell Derived Factor-1α

Regulation of C-Kit+ Progenitor Cells by Stromal Cell Derived Factor-1Α in Adult Murine Heart.

Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.

Hypoxic Preconditioning Improves Survival of Cardiac Progenitor Cells: Role of Stromal Cell Derived Factor-1α–CXCR4 Axis

Transcription factor-induced activation of cardiac gene expression in human c-kit+ cardiac progenitor cells

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

The Role ofNotch 1Activation in Cardiosphere Derived Cell Differentiation

Insulin-like growth factor-1-mediated regulation of miR-193a expression promotes the migration and proliferation of c-kit-positive mouse cardiac stem cells

Mesenchymal Stem Cells Enhance the Differentiation of C-Kit+ Cardiac Stem Cells.

Isolation and characterization of a Sca-1 + /CD31 - progenitor cell lineage derived from mouse heart tissue

The role of notch 1 activation in cardiosphere derived cell differentiation.

Single-cell transcriptome and epigenomic reprogramming of cardiomyocyte-derived cardiac progenitor cells

SCF/c-kit transactivates CXCR4-serine 339 phosphorylation through G protein-coupled receptor kinase 6 and regulates cardiac stem cell migration

Abstract 16620: Enhancing Transplanted Cardiac Progenitor Cells Homing and Survival in Ischemic Heart by CRISPR-dcas9/sgRNA-based Endogenous CXCR4 Promoter Activation

Cardiac Progenitor-Derived Exosomes Protect Ischemic Myocardium from Acute Ischemia/reperfusion Injury.

Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK

Lineage Reprogramming Of Fibroblasts Into Expandable Cardiac Progenitor Cells By Defined Small Molecules

The Effects of Mesenchymal Stem Cells on C-Kit Up-Regulation and Cell-Cycle Re-Entry of Neonatal Cardiomyocytes Are Mediated by Activation of Insulin-Like Growth Factor 1 Receptor

Inhibition of Oct 3/4 mitigates the cardiac progenitor-derived myocardial repair in infarcted myocardium

Epigenomic Reprogramming of Adult Cardiomyocyte-Derived Cardiac Progenitor Cells

Stromal Cell-Derived Factor-1 Promotes Bone Marrow-Derived Cells Differentiation to Cardiomyocyte Phenotypes in Vitro.